Pine River Capital Management’s Merck MRK Stock Holding History

Pine River Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-23,580	Closed	-$1.19M	–	526
2016 Q1	$1.19M	Buy	+23,580	New	+$1.15M	0.02%	366
2015 Q4	–	Sell	-10,794	Closed	-$509K	–	713
2015 Q3	$509K	Buy	+10,794	New	+$573K	0.01%	475

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pine River Capital Management's MRK Position: Q2 2016 in Review

Pine River Capital Management sold out of Merck (MRK) in Q2 2016, closing a stake of 23,580 shares — an estimated $1.19M sold.

Pine River Capital Management first reported a position in MRK in Q3 2015 and held it in 2 quarters. The position peaked at $1.19M in Q1 2016. 1,761 funds tracked by Wall St. Rank hold MRK as of Q2 2016.

Pine River Capital Management reported no remaining Merck position as of Q2 2016 after selling out during the quarter.
Pine River Capital Management sold 23,580 Merck shares in Q2 2016, an estimated $1.19M.
Pine River Capital Management first reported a position in Merck in Q3 2015 and held it in 2 quarters.
Pine River Capital Management's Merck position peaked at $1.19M in Q1 2016.
1,761 funds tracked by Wall St. Rank held Merck as of Q2 2016.

Based on Pine River Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.